BMO reiterates Toast stock rating on cyclical chip cost view By Investing.com

BMO Capital reiterated an Outperform rating on Toast with a $35 price target, arguing memory chip cost pressure is cyclical and that the market is overpricing a structural margin reset. The firm sees about 150 basis points of EBITDA upside by 2027 as pricing normalizes, despite Toast’s recent Q1 2026 EPS miss of $0.20 vs. $0.27 consensus. Revenue met expectations at $1.63 billion, but recent target cuts from Mizuho, Truist, and DA Davidson highlight near-term caution.

Analysis

The more important signal is not the buy rating itself, but the market’s tendency to reprice a cyclical input shock as a permanent margin reset. That creates a setup where the first derivative matters less than the inflection in forward estimates: if input costs are already peaking, the next catalyst is not an earnings beat but a sequence of smaller-than-feared guide-downs, which can trigger multiple expansion well before EBITDA actually re-accelerates.

Consensus is also likely underweighting management’s ability to offset through pricing, mix, and supplier renegotiation. For software-led vertical platforms, margin compression from hardware components usually looks most severe at the trough of the cost cycle, then unwinds faster than the sell-side model because recurring revenue growth compounds on a larger installed base while procurement normalization lags only a few quarters.

The contrarian risk is timing: if the macro backdrop weakens, even a cyclical thesis can stall because customers delay openings and hardware refreshes, blunting the offset from pricing. The key watch item over the next 1-2 quarters is not absolute cost level, but whether gross margin stabilization arrives before further estimate cuts; if it does, the stock can rerate quickly, but if guidance remains conservative, the “cheap” valuation can stay cheap.

Among the other names, the common thread is not isolated stock-specific alpha but a broader analyst-narrative reset after cautious guidance. That tends to favor the highest-quality compounding businesses with durable end-demand and penalize names where near-term execution is still being digested, so the tape should differentiate sharply between true fundamental resilience and merely lowered expectations.

Key Decisions for Investors

• Long TOST on weakness over the next 1-3 weeks; target a 10-15% rebound if margin-stabilization comments start to re-enter the narrative. Use a tight 6-8% stop because the setup breaks if another cost-driven guide cut appears.
• Buy TOST Jan-2027 calls or call spreads to express the cyclical-margin-recovery thesis with limited downside; the risk/reward improves if the market re-rates the stock on forward EBITDA before the fundamentals fully show up.
• Pair trade: long TOST / short a basket of lower-quality software or vertical-SaaS names with similar multiple expansion but weaker operating leverage; the edge is in post-guidance estimate revision asymmetry over the next 1-2 quarters.
• Do not chase the move in AGYS/CVNA/NET/FAST/RGEN purely on analyst-list inclusion; wait for either a pullback or a confirming revision cycle, since the current signal is sentiment-driven and likely to fade without follow-through.
• If TOST reclaims prior resistance on improving street estimates, add on momentum for a 3-6 month hold; if not, monetize strength quickly because the market is still pricing a structural issue and will punish any hint of renewed margin pressure.